Consequently, the expression of particular TP63 isoforms has been connected with clinical outcomes across multiple cancer subtypes, and there is a potential tumor suppressive role for TP63 that is more prominent for certain isoforms [48,49]. The gene discussed is TP63; the disease is neoplasm.